0001209191-20-035039.txt : 20200608
0001209191-20-035039.hdr.sgml : 20200608
20200608173733
ACCESSION NUMBER: 0001209191-20-035039
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200605
FILED AS OF DATE: 20200608
DATE AS OF CHANGE: 20200608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Duncan Barbara Gayle
CENTRAL INDEX KEY: 0001353128
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38085
FILM NUMBER: 20950175
MAIL ADDRESS:
STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC.
STREET 2: 18 DESBROSSES STREET
CITY: NEW YORK
STATE: NY
ZIP: 10013
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ovid Therapeutics Inc.
CENTRAL INDEX KEY: 0001636651
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465270895
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1460 BROADWAY
STREET 2: SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 212-776-4381
MAIL ADDRESS:
STREET 1: 1460 BROADWAY
STREET 2: SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-05
0
0001636651
Ovid Therapeutics Inc.
OVID
0001353128
Duncan Barbara Gayle
C/O OVID THERAPEUTICS INC.
1460 BROADWAY, SUITE 15044
NEW YORK
NY
10036
1
0
0
0
Stock Option (Right to Buy)
5.29
2020-06-05
4
A
0
13250
0.00
A
2030-06-04
Common Stock
13250
13250
D
The option will vest in full on June 5, 2021, subject to the Reporting Person's continuous service through such vesting date.
/s/ Danielle Mann for Barbara G. Duncan by POA
2020-06-08